"Our study focused on determining the positivity rate of CTA, and whether thromboembolic risk-factor assessment can accurately indicate the pretest probability of PE," said Dr. Mark Mamlouk from the University of California, Irvine. "We did a retrospective chart review of 2,003 patients suspicious of having PE using statistical regression analysis. Additionally, we analyzed the role of D-dimers."
More than 90% of the patients had a negative CTA, he said. Without thromboembolic risk factors, it was extremely unlikely (1.3%) to have a positive CTA. "Furthermore, with the combination of no risk factors and negative D-dimer results, the risk became extremely low. The study suggests that CTA use can be markedly reduced, resulting in cost-savings and decreased radiation exposure," he said.